In all three breast cancer cell lines examined, FGF1 treatment upregulated genes involved in cell proliferation (e.g., E2F targets, G2M checkpoint) and metabolism (e.g., cholesterol homeostasis, glycolysis), but there was not a significant enrichment of genes linked to invasion or metastasis. Here, FGF1 is linked to breast cancer.